A novel live Pichinde virus-based vaccine vector induces enhanced humoral and cellular immunity after a booster dose

Rekha Dhanwani, Yanqin Zhou, Qinfeng Huang, Vikram Verma, Mythili Dileepan, Hinh Ly, Yuying Liang

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Abstract

Pichinde virus (PICV) is a bisegmented enveloped RNA virus that targets macrophages and dendritic cells (DCs) early in infection and induces strong innate and adaptive immunity in mice. We have developed a reverse genetics system to produce live recombinant PICV (strain P18) with a trisegmented RNA genome (rP18tri), which encodes all four PICV gene products and as many as two foreign genes. We have engineered the vector to express the green fluorescent protein (GFP) reporter gene (abbreviated as G in virus designations) and either the hemagglutination (HA [H]) or the nucleoprotein (NP [P]) gene of the influenza A/PR8 virus. The trisegmented viruses rP18tri-G/H and rP18tri-G/P showed slightly reduced growth in vitro and expressed HA and NP, respectively. Mice immunized with rP18tri-G/H were completely protected against lethal influenza virus challenge even 120 days after immunization. These rP18tri-based vectors could efficiently induce both neutralizing antibodies and antigen-specific T cell responses via different immunization routes. Interestingly, the immune responses were significantly increased upon a booster dose and remained at high levels even after three booster doses. In summary, we have developed a novel PICV-based live vaccine vector that can express foreign antigens to induce strong humoral and cell-mediated immunity and is ideal for a primeand- boost vaccination strategy.

Original languageEnglish (US)
Pages (from-to)2551-2560
Number of pages10
JournalJournal of virology
Volume90
Issue number5
DOIs
StatePublished - 2016

Bibliographical note

Publisher Copyright:
© 2016, American Society for Microbiology.

Fingerprint

Dive into the research topics of 'A novel live Pichinde virus-based vaccine vector induces enhanced humoral and cellular immunity after a booster dose'. Together they form a unique fingerprint.

Cite this